Boston Scientific (BSX) Acquisitions (2009 - 2026)

Boston Scientific (BSX) has 17 years of Acquisitions data on file, last reported at $523.0 million in Q1 2026.

• For the quarter ending Q1 2026, Acquisitions rose 118.83% year-over-year to $523.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 64.94% YoY), and the FY2025 full-year result was $1.6 billion, down 65.67% from the prior year.
• Acquisitions climbed to $523.0 million in Q1 2026, from $89.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $3.4 billion in Q4 2024 to a low of $47.0 million in Q1 2024.
• A 5-year average of $709.0 million and a median of $449.0 million in 2023 frame the typical range for Acquisitions.
• Peak annual rise in Acquisitions reached 2002.08% in 2025, while the deepest fall reached 97.4% in 2025.
• Tracing BSX's Acquisitions over 5 years: stood at $71.0 million in 2022, then jumped by 1016.9% to $793.0 million in 2023, then surged by 331.02% to $3.4 billion in 2024, then tumbled by 97.4% to $89.0 million in 2025, then jumped by 487.64% to $523.0 million in 2026.
• Business Quant data shows BSX's Acquisitions at $523.0 million in Q1 2026, $89.0 million in Q4 2025, and $73.0 million in Q3 2025.